The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis

Authors

  • Alexandra Arcilla Xin Hui Sim
  • Jia Ying Cheam
  • Jodi Woan-Fei Law
  • Vengadesh Letchumanan
  • Yatinesh Kumari
  • Satoshi Ogawa
  • Sunny Hei Wong
  • Kok-Gan Chan
  • Loh Teng-Hern Tan

DOI:

https://doi.org/10.36877/pmmb.a0000339

Abstract

Colorectal cancer (CRC) remains one of the top cancers in the world. Although early detection improves the survival rate to around 90%, late detection would mean the need to use chemotherapy or radiotherapy, especially if surgery is not feasible. 5-fluorouracil (5-FU) is one of the common anti-cancer drugs used in treating CRC. It is the drug that has the greatest efficacy on CRC. Although it improves the survival rate, it has many detrimental side effects. One of these side effects is intestinal mucositis. It is described as having reduced villus height, villus atrophy, crypt fissure, abdominal discomfort, diarrhoea, and weight loss. Clinically, there is no conclusive treatment therapy for mucositis. This is possibly due to the complex mechanism of the pathobiology of intestinal mucositis that includes the production of pro-inflammatory cytokines and increased epithelial cell apoptosis. 5-FU itself is known to cause gut dysbiosis. Current studies revealed probiotics play a role in attenuating this inflammatory process of intestinal mucositis by reversing gut dysbiosis, reducing the expression of pro-inflammatory cytokines, and reducing intestinal damage. This review outlines the latest evidence supporting probiotic use in ameliorating 5-FU induced intestinal mucositis, thereby promoting good health and well-being in colorectal cancer patients receiving 5-FU chemotherapy.

Downloads

Published

2023-07-16

How to Cite

Sim, A. A. X. H. ., Cheam, J. Y. ., Law, J. W.-F., Letchumanan, V., Kumari, Y., Ogawa, S., Wong, S. H., Chan, K.-G., & Tan, L. T.-H. (2023). The Ameliorative Role of Probiotics in 5-fluorouracil Induced Intestinal Mucositis. Progress In Microbes & Molecular Biology, 6(1). https://doi.org/10.36877/pmmb.a0000339

Issue

Vol. 6 No. 1 (2023)

Section

Review Articles

License

Copyright (c) 2023 Alexandra Arcilla Xin Hui Sim, Jia Ying Cheam, Jodi Woan-Fei Law, Vengadesh Letchumanan, Yatinesh Kumari, Satoshi Ogawa, Sunny Hei Wong, Kok-Gan Chan, Loh Teng-Hern Tan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:

Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.

 

This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.

The author(s) permits HH Publisher to publish this article that has not been submitted elsewhere.

Abstract viewed = 977 times
PDF downloaded = 442 times